Esther Lopez-Gonzalez
Rowland Hill Street
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B.
Journal: Journal of the American College of Cardiology
Published: June 22, 2026
Cascade genetic screening in hereditary transthyretin amyloidosis: when early diagnosis becomes survival.
Journal: European heart journal
Published: April 15, 2026
MR-ProADM Predicts Mortality and Heart Failure Events in ATTR Cardiac Amyloidosis.
Journal: Circulation
Published: March 31, 2026
Improving transthyretin cardiac amyloidosis detection from electrocardiograms through the Willem artificial intelligence platform.
Journal: Heart rhythm
Published: January 27, 2026
Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy.
Journal: Circulation. Heart failure
Published: September 24, 2025
High CA125 levels as a red flag for ATTR Cardiac Amyloidosis.
Journal: ESC heart failure
Published: July 03, 2025
Detection of Titin-Associated Electrocardiography Features in Dilated Cardiomyopathy Using Conventional and Deep Neural Network Analysis.
Journal: JACC. Clinical electrophysiology
Published: June 12, 2025
Association of genotype with treatment response and prognosis in dilated cardiomyopathy.
Journal: Revista espanola de cardiologia (English ed.)
Published: June 05, 2025
Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy.
Journal: European journal of heart failure
Published: May 23, 2025
Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association.
Journal: European heart journal
Published: April 14, 2025
Last Updated: 09/26/2026